Aspergillosis prior to bone marrow transplantation. Infectious Diseases Working Party of the EBMT and the EORTC Invasive Fungal Infections Cooperative Group.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Bone Marrow Transplantation

• Publication date

  1995-08-01

• Fields of study

  Medicine

• Identifiers
  PMID 7581159
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases.

  1990cited by this paper
• Fungal infections in bone marrow transplant patients.

  1990cited by this paper

• Routine Infectious Disease Consultation Prior to an Allogeneic Hematopoietic Cell Transplant

  2023cites this paper
• A Disseminated Fusarium fujikuroi Species Complex Infection Prior to Allogeneic Hematopoietic Stem Cell Transplantation.

  2020cites this paper
• How I transplant a patient with a history of invasive fungal disease.

  2020cites this paper
• Invasive Fungal Disease in the Transplant Population: An Overview

  2019cites this paper
• Antifungal agents for secondary prophylaxis based on response to initial antifungal therapy in allogeneic hematopoietic stem cell transplant recipients with prior pulmonary aspergillosis.

  2014cites this paper
• Voriconazole is Effective as Secondary Antifungal Prophylaxis in Leukemia Patients with Prior Pulmonary Fungal Disease: Case Series and Review of Literature

  2011cites this paper
• Hematopoietic Stem Cell Transplantation in a Very High Risk Group of Patients with the Support of Granulocyte Transfusion

  2011cites this paper
• Update in Haematopoietic Stem Cell Transplantation

  2011cites this paper
• Voriconazole for secondary prophylaxis of invasive fungal infections in allogeneic stem cell transplant recipients: results of the VOSIFI study

  2010cites this paper
• Successful treatment of refractory Langerhans cell histiocytosis with pulmonary aspergillosis by reduced‐intensity conditioning cord blood transplantation

  2010cites this paper
• Phase-dependent antifungal activity against Aspergillus fumigatus developing multicellular filamentous biofilms.

  2008cites this paper
• Risk factors for breakthrough invasive fungal infection during secondary prophylaxis.

  2008cites this paper
• Invasive aspergillosis and allogeneic hematopoietic stem cell transplantation in children: a 15‐year experience

  2008cites this paper
• Hematopoietic stem cell transplantation in patients with active fungal infection: not a contraindication for transplantation.

  2008cites this paper
• Efficacy of caspofungin as secondary prophylaxis in patients undergoing allogeneic stem cell transplantation with prior pulmonary and/or systemic fungal infection

  2007cites this paper
• Clinical issues regarding relapsing aspergillosis and the efficacy of secondary antifungal prophylaxis in patients with hematological malignancies.

  2006cites this paper
• Impact of the intensity of the pretransplantation conditioning regimen in patients with prior invasive aspergillosis undergoing allogeneic hematopoietic stem cell transplantation: A retrospective survey of the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantati

  2006cites this paper
• Characterization and Comparison of Galactomannan Enzyme Immunoassay and Quantitative Real-Time PCR Assay for Detection of Aspergillus fumigatus in Bronchoalveolar Lavage Fluid from Experimental Invasive Pulmonary Aspergillosis

  2006cites this paper
• Regarding Relapsing Aspergillosis and the Efficacy of Secondary Antifungal Prophylaxis in Patients with Hematological Malignancies

  2006cites this paper
• Antifungal prophylaxis following reduced‐intensity stem cell transplantation

  2005cites this paper
• B iches Usher Dilemmas : Antifungal Therapy in nvasive Aspergillosis

  2005cites this paper
• Haemopoietic Cell Transplantation of Patients with a History of Deep or Invasive Fungal Infection during Prophylaxis with Liposomal Amphotericin B

  2005cites this paper
• Riches usher dilemmas: antifungal therapy in invasive aspergillosis.

  2005cites this paper
• [Fungal prophylaxis following reduced-intensity stem cell transplantation (RIST)].

  2004cites this paper
• Secondary antifungal prophylaxis with voriconazole to adhere to scheduled treatment in leukemic patients and stem cell transplant recipients

  2004cites this paper
• Invasive aspergillosis before allogeneic hematopoietic stem cell transplantation: 10-year experience at a single transplant center.

  2004cites this paper
• Aspergillosis in bone marrow transplant recipients.

  2000cites this paper
• Fungal infections after bone marrow transplant.

  1999cites this paper
• Impact of previous aspergillosis on the outcome of bone marrow transplantation.

  1998cites this paper
• The European Group for Blood and Marrow Transplantation (EBMT): a report from the president and the chairmen of the working parties.

  1996cites this paper